James W JR Traweek Insider Profile
4 Followers
James W JR Traweek, former Ten Percent Owner at Apollo Endosurgery, holds 1.33M shares in Apollo Endosurgery (Ticker: APEN), holds 3.15M shares in Reata Pharmaceuticals (Ticker: RETA).
James W JR Traweek's Trading History
| APENApollo Endosurgery | Jan 06, 2020 | ― | Uninformative Buy | ― | $13.30M | |
| RETAReata Pharmaceuticals | Jan 02, 2020 | ― | Uninformative Buy | ― | $543.22M |
You May Also Like
James W JR Traweek insider profile FAQ
What is the percentage of profitable transactions made by James W JR Traweek?
The percentage of profitable transactions made by James W JR Traweek is 80%.
What is the average return per transaction made by James W JR Traweek?
The average return per transaction made by James W JR Traweek is 107.90%.
What stocks does James W JR Traweek hold?
James W JR Traweek holds: APEN, RETA stocks.
What was James W JR Traweek's most profitable transaction?
James W JR Traweek’s most profitable transaction was an Informative Buy of RETA stock on December 12, 2018. The return on the trade was 231.70%.
What is James W JR Traweek's role in Apollo Endosurgery?
James W JR Traweek's role in Apollo Endosurgery is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
